Hi, today we are going to talk about VistaGen Therapeutics Inc and its current landscape. VistaGen Therapeutics Inc despite the high volatility of this penny stock it could be hiding a gold mine as the company has received Fast Track designation by the FDA for the development of the company's PH94B neuroactive nasal spray for on-demand treatment of social...
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines to treat diseases and disorders of the central nervous system. Its portfolio focuses on three clinical-stage product; neuropathic pain (NP), levodopa-induced dyskinesia (LID), social anxiety disorder (SAD) and suicidal ideation...
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines to treat diseases and disorders of the central nervous system. Its portfolio focuses on three clinical-stage product; neuropathic pain (NP), levodopa-induced dyskinesia (LID), social anxiety disorder (SAD) and suicidal ideation...
What goes up must come down. . . . and then it will go up again.
I really like VTGN for 01/11-01/18 trading, if we can break 1.75 today we could see a serious rally into the 2's, trading is pretty choppy, but still nice upside potential for the week.
VTGN: VistaGen Therapeutics, Inc. 2018-10-03 08:30:00 VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain